G. Thomas Budd

14.8k citations
177 papers · 10.0k · 4 hit papers · h-index 37

Impact in

  • Oncology top 0.1%
    • Cancer Cells and Metastasis
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 30
    • HER2/EGFR in Cancer Research 23
    • Vascular Tumors and Angiosarcomas 10
    • Sarcoma Diagnosis and Treatment 14
    • Advanced Breast Cancer Therapies 12

G. Thomas Budd

170 papers receiving 9.8k citations

G. Thomas Budd's Hit Papers

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival 2006 · 808 citations
8080+7+14Years since publication10002.0k3.0k

Peers

G. Thomas Budd
Comparison fields: 5 of 135
  • Oncology 5.9k
  • Cancer Research 3.1k
  • Pulmonary and Respiratory Medicine 2.0k
  • Biomedical Engineering 1.4k
  • Cardiology and Cardiovascular Medicine 633
Replace Stefan Sleijfer with:
Stefan Sleijfer Netherlands
Jean‐Yves Pierga France
Nuh N. Rahbari Germany
Volkmar Müller Germany
Sabino De Placido Italy
Suzette Delaloge France
Luc Dirix Belgium
Patricia Keegan United States
Giampietro Gasparini Italy
Chris Twelves United Kingdom
G. Thomas Budd relative to Stefan Sleijfer Netherlands Stefan Sleijfer's profile →
Citations per field
00.5×1.5×
Stefan Sleijfer · 1×
Citations per year

Countries citing papers authored by G. Thomas Budd

Since Specialization
Citations

This map shows the geographic impact of G. Thomas Budd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Thomas Budd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Thomas Budd more than expected).

Fields of papers citing papers by G. Thomas Budd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Thomas Budd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Thomas Budd. The network helps show where G. Thomas Budd may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Thomas Budd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Thomas Budd Line = papers co-authored together G. Thomas Budd links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Hit paper breakdown →
20043583
2
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Hit paper breakdown →
2005860
3
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
Hit paper breakdown →
2006808
4
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Hit paper breakdown →
2006596
5 2012243
6 2006213
7 2019160
8 2006136
9 2013120
10 2021112
11 1988112
12 2008111
13 201483
14 202182
15 201282
16
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
199180
17 200678
18 200276
19 200671
20 200670

About G. Thomas Budd

G. Thomas Budd is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 177 papers that have together received 10.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (30 papers), Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (23 papers), Sarcoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Advanced Breast Cancer Therapies (12 papers), Vascular Tumors and Angiosarcomas (10 papers) and Estrogen and related hormone effects (9 papers). The work is most often cited by research in Oncology (5.9k citations), Cancer Research (3.1k citations), Pulmonary and Respiratory Medicine (2.0k citations), Biomedical Engineering (1.4k citations) and Cardiology and Cardiovascular Medicine (633 citations). G. Thomas Budd has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Daniel F. Hayes, Michael Craig Miller, Leon W.M.M. Terstappen, Jeri Matera, Massimo Cristofanilli, Gerald V. Doyle, W. Jeffrey Allard, Alison Stopeck, Matthew J. Ellis and James M. Reuben. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact